| Literature DB >> 36076118 |
Joseph W Fredrick1,2, Kerensa Nagle3, Joshua M Langberg4, Melissa R Dvorsky5,6, Rosanna Breaux7, Stephen P Becker3,8.
Abstract
The current prospective longitudinal study evaluated brooding rumination as an intervening mechanism of the association between COVID-19-related stress and internalizing symptoms during the first year of the pandemic. Attention-deficit/hyperactivity disorder (ADHD) status and adolescent sex were tested as moderators of the indirect effect. Adolescents with and without ADHD (N = 238; M age = 16.74) completed rating scales of COVID-19 stress and both adolescents and parents completed ratings scales of internalizing symptoms in May/June 2020 (T1). In October/November 2020 (T2), adolescents reported on their brooding rumination. Adolescents and parents reported on internalizing symptoms again in March/April 2021 (T3). Covariates included participant characteristics and baseline symptoms. T1 self-reported COVID-19-related stress was associated with increased T3 self-reported anxiety (ab = 0.10), self-reported depression (ab = 0.07), and parent-reported depression (ab = 0.09) via T2 brooding rumination. The indirect effect did not differ for adolescents with and without ADHD or for female and male adolescents. Brooding rumination may be one mechanism to target to promote the mental health adjustment of adolescents during periods of high stress of the COVID-19 pandemic and future stressors.Entities:
Keywords: Adolescence; Anxiety; COVID-19; Depression; Rumination; Stress
Year: 2022 PMID: 36076118 PMCID: PMC9458302 DOI: 10.1007/s10578-022-01435-3
Source DB: PubMed Journal: Child Psychiatry Hum Dev ISSN: 0009-398X
Means, standard deviations, and bivariate correlations among study variables
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Sex | – | |||||||||||||
| 2. Med | 0.03 | – | ||||||||||||
| 3. Group | − 0.20** | 0.48** | – | |||||||||||
| 4. School | − 0.00 | 0.01 | 0.05 | – | ||||||||||
| 5. SR T1 Stress | 0.35** | 0.15* | − 0.04 | − 0.03 | – | |||||||||
| 6. SR T1 Dep | 0.31** | 0.18** | 0.05 | 0.11 | 0.62** | – | ||||||||
| 7. SR T1 Anx | 0.33** | 0.18** | 0.01 | 0.06 | 0.66** | 0.75** | – | |||||||
| 8. PR T1 Dep | 0.07 | 0.30** | 0.25* | 0.16* | 0.26** | 0.50** | 0.32** | – | ||||||
| 9. PR T1 Anx | 0.16* | 0.29** | 0.18** | 0.11 | 0.29** | 0.37** | 0.44** | 0.71** | – | |||||
| 10. SR T2 Rumination | 0.17* | 0.23** | 0.11 | − 0.07 | 0.51** | 0.56** | 0.58** | 0.21** | 0.25** | – | ||||
| 11. SR T3 Dep | 0.27** | 0.12 | 0.10 | 0.03 | 0.40** | 0.64** | 0.45** | 0.39* | 0.25** | 0.56** | – | |||
| 12. SR T3 Anx | 0.35** | 0.17* | 0.09 | 0.01 | 0.46** | 0.52** | 0.60** | 0.26** | 0.35** | 0.64** | 0.78** | – | ||
| 13. PR T3 Dep | 0.12 | 0.25** | 0.22** | 0.10 | 0.29** | 0.48** | 0.33** | 0.73** | 0.53** | 0.38** | 0.54** | 0.48** | – | |
| 14. PR T3 Anx | 0.28** | 0.20** | .17 | 0.10 | 0.36** | 0.36** | 0.43** | 0.48** | 0.71** | 0.35** | 0.42** | 0.60** | 0.66** | – |
| Mean | – | – | – | – | 2.18 | 0.72 | 0.58 | 0.46 | 0.33 | 7.72 | 0.70 | 0.52 | 0.44 | 0.32 |
| SD | – | – | – | – | 0.85 | 0.55 | 0.46 | 0.42 | 0.28 | 2.77 | 0.59 | 0.45 | 0.39 | 0.30 |
For sex, 0 male participant, 1 female participant. For med, 0 no medication, 1 current medication. For group, 0 comparison, 1 ADHD. For school, 0 in-person, 1 = remote. T1 timepoint 1. T2 timepoint 2. T3 timepoint 3. SR adolescent self-report. PR parent-report. Stress COVID-19 stress. Dep depression. Anx Anxiety
*p < 0.05,**p < 0.01
Fig. 1Mediation results of T1 COVID-19 stress, T2 brooding rumination, and T3 self-reported depression symptoms (top figure) and anxiety symptoms (bottom figure)
Indirect effect results of T1 COVID-19 stress, T2 brooding rumination, and T3 self- and parent-reported depression and anxiety symptoms
| Indirect effect | Adolescent-report | Parent-report | ||||||
|---|---|---|---|---|---|---|---|---|
| ab | SE | 95% CI | ab | SE | 95% CI | |||
| T1 Stress → T2 Rumination → T3 Depression | 0.074 | 0.026 | 0.010, 0.111 | 0.039 | 0.094 | 0.036 | 0.014, 0.080 | 0.009 |
| T1 Stress → T2 Rumination → T3 Anxiety | 0.102 | 0.048 | 0.008, 0.113 | 0.033 | 0.060 | 0.031 | 0.000, 0.045 | 0.057 |
All analyses also controlled for ADHD group status, sex, T1 medication status, school type (remote vs. in-person), and baseline symptoms ratings. Standardized ab indirect effect and unstandardized confidence intervals are presented
Fig. 2Mediation results of T1 COVID-19 stress, T2 brooding rumination, and T3 parent-reported depression symptoms (top figure) and anxiety symptoms (bottom figure)